<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-JV6H7OTP</identifier><date>2004</date><creator>Borštnar, Simona</creator><creator>Jezeršek Novaković, Barbara</creator><creator>Tomšič, Radka</creator><creator>Vovk, Marjeta</creator><relation>documents/doc/J/URN_NBN_SI_doc-JV6H7OTP_001.pdf</relation><relation>documents/doc/J/URN_NBN_SI_doc-JV6H7OTP_001.txt</relation><format format_type="issue">1</format><format format_type="volume">38</format><format format_type="type">article</format><format format_type="extent">str. 15-19</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">17662681</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-JV6H7OTP</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>InC</rights><subject language_type_id="slv">Antibodies, Monoclonal</subject><subject language_type_id="slv">Antigeni, CD20</subject><subject language_type_id="slv">Antigens, Cd20</subject><subject language_type_id="slv">Drug Therapy</subject><subject language_type_id="slv">limfom</subject><subject language_type_id="slv">Lymphoma, Non-Hodgkin'S</subject><subject language_type_id="slv">protitelesa</subject><subject language_type_id="slv">Protitelesa monoklonska</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="slv">Therapeutic Use</subject><subject language_type_id="slv">Treatment Outcome</subject><subject language_type_id="slv">zdravljenje</subject><subject language_type_id="slv">Zdravljenje, izid</subject><title>Rituximab affects the prognosis of patients with nonHodgkin's lymphomas</title></Record>